scholarly journals The Role of Patent Foramen Ovale Closure in the Secondary Prevention of Cryptogenic Stroke: a Meta-Analysis Report

Author(s):  
Sónia P. Pinto Pereira ◽  
Alzira Nunes ◽  
Cristina Santos ◽  
Scott E. Kasner ◽  
José P. L. Nunes
2018 ◽  
Vol 13 (8) ◽  
pp. 1287-1303 ◽  
Author(s):  
Elisa Maria Fiorelli ◽  
Tiziana Carandini ◽  
Delia Gagliardi ◽  
Viviana Bozzano ◽  
Mattia Bonzi ◽  
...  

2018 ◽  
Vol 131 (5) ◽  
pp. 575-577 ◽  
Author(s):  
Muthiah Vaduganathan ◽  
Arman Qamar ◽  
Ankur Gupta ◽  
Navkaranbir Bajaj ◽  
Harsh B. Golwala ◽  
...  

2011 ◽  
Vol 6 (1) ◽  
pp. 67
Author(s):  
Antonio L Bartorelli ◽  
Claudio Tondo ◽  
◽  

Innovative percutaneous procedures for stroke prevention have emerged in the last two decades. Transcatheter closure of the patent foramen ovale (PFO) is performed in patients who suffered a cryptogenic stroke or a transient ischaemic attach (TIA) in order to prevent recurrence of thromboembolic events. Percutaneous occlusion of the left atrial appendage (LAA) has been introduced to reduce stroke risk in patients with atrial fibrillation (AF). The role of PFO and LAA in the occurrence of cerebrovascular events and the interventional device-based therapies to occlude the PFO and LAA are discussed.


Author(s):  
Harsha S. Nagarajarao ◽  
Chandra P. Ojha ◽  
Archana Kedar ◽  
Debabrata Mukherjee

: Cryptogenic stroke and its relation to the Patent Foramen Ovale (PFO) is a long-debated topic. Recent clinical trials have unequivocally established the relationship between cryptogenic strokes and paradoxical embolism across the PFO. This slit-like communication exists in everyone before birth, but most often closes shortly after birth. PFO may persist as a narrow channel of communication between the right and left atria in approximately 25-27% of adults. : In this review, we examine the clinical relevance of the PFO with analysis of the latest trials evaluating catheter-based closure of PFO’s for cryptogenic stroke. We also review the current evidence examining the use of antiplatelet medications versus anticoagulants for stroke prevention in those patients with PFO who do not qualify for closure per current guidelines.


2014 ◽  
Vol 111 (04) ◽  
pp. 773-776 ◽  
Author(s):  
Monica Gianni ◽  
Nicola Mumoli ◽  
Marco Cei ◽  
Andrea Bertolini ◽  
Luigina Guasti ◽  
...  

2019 ◽  
Vol 20 (8) ◽  
pp. 687-694 ◽  
Author(s):  
Puja Sitwala ◽  
Muhammad Faisal Khalid ◽  
Furqan Khattak ◽  
Jayant Bagai ◽  
Sukhdeep Bhogal ◽  
...  

Stroke ◽  
2018 ◽  
Vol 49 (Suppl_1) ◽  
Author(s):  
Georgios Tsivgoulis ◽  
Aristeidis H Katsanos ◽  
Dimitris Mavridis ◽  
Alexandra Frogoudaki ◽  
Agathi-Rosa Vrettou ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document